1FALCK B, HILLARP N A, THIEME G, et al. Fluorescence of catecholamines and related compounds condensed with formaldehyde[J]. The Journal of Histochemistry and Cyto- chemistry, 1962,10 : 348-354.
2GERMAN D C, MANAYE K F. Midbrain dopaminergic neu- rons (nuclei A8, A9, and A10): three-dimensional recon- struction in the rat[J]. The Journal of Comparative Neurolo-gy, 1993,331:297-309.
3BOGERTS B, HANTSCH J, HERZER M. Amorphometric study of the dopamine-containing cell groups in the mesence- phalon of normals, Parkinson patients, and schizophrenics[J]. Biological Psychiatry, 1983,18 :951-969.
4CHINTA S J, ANDERSEN J K. Dopaminergie neurons[J]. The International Journal of Biochemistry&Cell Biology, 2005,37: 942-946.
5PARKINSON J. An essay on the slaaking palsy. 1817[J]. The Journal of Neuropsychiatry & Clinical Neurosciences, 2002,14 ; 222-236.
10Rodriguez-Oroz ME,Obeso JA,Lang AE,et al.Bilateral deep brain stimulation in Parkinson's disease:a multicentre study with 4 years follow-up.Brain,2005,128(Pt 10):2240-2249.
2Choong Hyun Lee,Ji Hyeon Ahn,Joon Ha Park,Bing Chun Yan,In Hye Kim,Dae Hwan Lee,Jeong-Hwi Cho,Bai Hui Chen,Jae-Chul Lee,Jun Hwi Cho,Yun Lyul Lee,Moo-Ho Won,Il-Jun Kang.Decreased Insulin-Like Growth Factor-I and Its Receptor Expression in the Hippocampus and Somatosensory Cortex of the Aged Mouse[J].Neurochemical Research.2014(4)
3Haim Werner,Derek LeRoith.Insulin and insulin-like growth factor receptors in the brain: Physiological and pathological aspects[J].European Neuropsychopharmacology.2014
4Qing He,Jianguo Sun,Qin Wang,Wei Wang,Bin He.Neuroprotective effects of ginsenoside Rg1 against oxygen–glucose deprivation in cultured hippocampal neurons[J].Journal of the Chinese Medical Association.2013
5Lei Wang,Hai-Jie Yang,Yin-Yan Xia,Zhi-Wei Feng.Insulin-like growth factor 1 protects human neuroblastoma cells SH-EP1 against MPP+-induced apoptosis by AKT/GSK-3β/JNK signaling[J].Apoptosis.2010(12)
6Qian Liu,Jun-Ping Kou,Bo-Yang Yu.Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation[J].Neurochemistry International.2010(1)
7LiXu,Wen‐FangChen,Man‐SauWong.Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson’s disease through the IGF‐I receptor signalling pathway[J].British Journal of Pharmacology.2009(3)
8ArnulfoQuesada,Becky Y.Lee,Paul E.Micevych.PI3 kinase/Akt activation mediates estrogen and IGF‐1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson’s disease[J].Devel Neurobio.2008(5)
9ArnulfoQuesada,Horacio E.Romeo,PaulMicevych.Distribution and localization patterns of estrogen receptor‐β and insulin‐like growth factor‐1 receptors in neurons and glial cells of the female rat substantia nigra: Localization of ERβ and IGF‐1R in substantia nigra[J].J Comp Neurol.2007(1)
10Klaus D Beck,Lyn Powell-Braxtont,Hans-R Widmer,Janet Valverde,Franz Hefti.Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons[J].Neuron.1995(4)
